Fabrication and evaluation of novel quercetin-conjugated Fe₃O₄–β-cyclodextrin nanoparticles for potential use in epilepsy disorder

Mona Hashemian1 Student Research Committee, Babol University of Medical Sciences , Babol, Iran

Maryam Ghasemi-Kasman2 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences , Babol, Iran;3 Neuroscience Research Center, Health Research Institute, Babol University of Medical Sciences , Babol, IranCorrespondence[email protected]

Shahram Ghasemi4 Faculty of Chemistry, University of Mazandaran, Babolsar, Iran

Atefeh Akbari5 Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences , Babol, Iran

Monire Moalem-Banhangi1 Student Research Committee, Babol University of Medical Sciences , Babol, Iran

Leila Zare3 Neuroscience Research Center, Health Research Institute, Babol University of Medical Sciences , Babol, Iran

Seyed Raheleh Ahmadian1 Student Research Committee, Babol University of Medical Sciences , Babol, Iran

show all

Fabrication and evaluation of novel quercetin-conjugated Fe₃O₄–β-cyclodextrin nanoparticles for potential use in epilepsy disorder

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Fabrication and evaluation of novel quercetin-conjugated Fe3O4–β-cyclodextrin nanoparticles for potential use in epilepsy disorder

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Fabrication and evaluation of novel quercetin-conjugated Fe₃O₄–β-cyclodextrin nanoparticles for potential use in epilepsy disorder